Thought Leadership
Read our insights and commentary about pharmaceutical industry news and healthcare innovation globally. Subscribe to our monthly newsletter to keep up to date with our thought leadership, news, and updates.
Showing 5 of 108 posts
May 18, 2020 | Research posters
ISPOR Annual 2020: The Resultant Impact of HEOR Data on US Payer Formulary Coverage
A research poster identifying instances where manufacturer HEOR data and/or pharmacoeconomic models either influenced positive changes, or had limited tangible impact on resultant US payer coverage decisions.
May 13, 2020 | Podcasts
Speaking of Access: The Management of Gene Therapies (Now and in the Future)
Andrew Gould asks our US payer panel for their expert perspectives surrounding the management of gene therapies, both now and in the future.
May 7, 2020 | Podcasts
CBPartners’ Pharma Take-Away: AMARIN’s VASCEPA patent loss: is it obvious(ness)?
Patent management is the hot topic of this episode. The focus is on AMARIN’s leading product, VASCEPA, a drug made up of natural derivatives such as fish oil and was approved by the FDA in December 2019.
May 5, 2020 | Podcasts
Speaking of Access: Pricing for Uncertain Indications
Andrew Gould asks our US payer panel for their expert perspectives surrounding pricing for uncertain future indications.
April 30, 2020 | Culture Blog, News
cbpGIVES Raises $4,150 Within the Firm to Support COVID-19 Relief Efforts
The global COVID-19 crisis has affected many individuals worldwide in substantial ways, including increasing food insecurity, medical burden and economic loss. CBPartners' charitable faction cbpGIVES coordinated efforts firm-wide to raise funds to support COVID-19 relief. CBPartners has matched every dollar raised by employees and have raised a total of $4,150 to donate to several organizations across the world.